Research Paper Volume 14, Issue 22 pp 9317—9337
High SURF4 expression is associated with poor prognosis of breast cancer
Figure 3. Expression of SURF4 in breast cancer and its relationship with clinicopathological parameters. Expression of SURF4 grouped by (A) age, (B) gender, (C) lymph node status, (D) margin status, (E) menopause status, (F) molecular subtype, (G) neoadjuvant treatment, (H) radiation therapy, (I) sample type, (J) targeted molecular therapy, and (K) vital status.